Close



Feb 9, 2023 05:11PM
Feb 2, 2023 09:00AM
Dec 12, 2022 06:00AM
Dec 6, 2021 04:00PM
Dec 1, 2021 01:28PM
Dec 5, 2020 03:00PM
Nov 30, 2020 04:04PM Amgen (AMGN) Announces New Data Being Presented At ASH 2020
Nov 30, 2020 04:00PM
Aug 24, 2020 08:44AM
Aug 24, 2020 08:30AM
Aug 20, 2020 05:34PM
Aug 20, 2020 05:33PM
Dec 10, 2019 07:33AM
Dec 10, 2019 07:30AM Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting
Dec 2, 2019 04:00PM
Oct 15, 2019 09:00AM
Sep 13, 2019 09:02AM
Sep 13, 2019 09:00AM
Jan 24, 2019 09:03AM
Jan 24, 2019 09:00AM
Nov 1, 2018 04:00PM Amgen To Present New Data Showcasing Extensive Portfolio And Exciting Early Oncology Pipeline At ASH 2018
Oct 1, 2018 09:01AM
Oct 1, 2018 09:00AM
Aug 27, 2018 09:03AM
Aug 27, 2018 09:00AM
Jun 27, 2018 09:04AM
Jun 27, 2018 09:00AM
Jun 11, 2018 09:01AM Amgen (AMGN) Announces FDA Approves Addition Of Positive OS Data From Phase 3 ASPIRE Trial To KYPROLIS Label
Jun 11, 2018 09:00AM
Jun 1, 2018 04:02PM
Jun 1, 2018 04:00PM
Apr 30, 2018 09:01AM
Apr 30, 2018 09:00AM
Jan 30, 2018 09:01AM
Jan 30, 2018 09:00AM Amgen Receives CHMP Positive Opinion To Add Updated Overall Survival Data To KYPROLIS® (carfilzomib) Label
Jan 17, 2018 04:22PM
Jan 17, 2018 04:15PM
Jan 17, 2018 04:11PM
Jan 17, 2018 04:09PM
Dec 11, 2017 04:03PM
Dec 11, 2017 04:00PM
Oct 23, 2017 04:02PM Amgen (AMGN) Says Phase 3 A.R.R.O.W. Study of Once-Weekly KYPROLIS Regimen Meet Primary Endpoint of Progression-Free Survival In R/R Multiple Myeloma Patients
Oct 23, 2017 04:00PM
Aug 30, 2017 04:21PM
Aug 30, 2017 04:18PM
Aug 30, 2017 04:01PM
Aug 30, 2017 04:00PM
Aug 23, 2017 06:43PM
Jul 14, 2017 09:01AM Amgen (AMGN) Submits sNDA in US And Europe to Include Overall Survival Data in KYPROLIS Label
Jul 14, 2017 09:00AM

55,525 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All